Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Post by investderpon Nov 09, 2015 4:36pm
298 Views
Post# 24274710

Journal article in Therapeutic Advances in Urology, 2015

Journal article in Therapeutic Advances in Urology, 2015Conclusion
BCG failure for patients with high-risk NMIBC is a common and serious problem. Although standard subsequent treatment is radical cystectomy, alternative intravesical treatments can be explored in appropriately selected patients. Trials must be designed carefully due to significant risk of disease progression in these patients. Based on existing evidence, MCNA appears to have a role as an effective treatment for patients with BCG failure. Comparisons of the safety and efficacy of MCNA to other second-line intravesical therapeutic agents are generally favorable. Further studies are needed to fully assess MCNA’s role in the continuously evolving landscape of intravesical treatment for NMIBC.
<< Previous
Bullboard Posts
Next >>